Rabies vaccine booster after pre-exposure doses
Part of Infections clinical trials.
This study tests whether a single booster dose of the rabies vaccine is still effective in people who received the primary pre-exposure series several years ago. It compares three different vaccine regimens to see which one boosts immunity best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have received a rabies pre-exposure vaccine series at least 5 years ago (either 3 shots in the arm or 2 shots under the skin, with two visits 5 to 56 days apart).
- You must not have had rabies vaccines after a possible exposure (post-exposure treatment).
- You must not have taken immune-suppressing medications in the last 3 months.
- You must not be pregnant or planning a pregnancy at the time of the booster shot.
- You must be willing to follow the study schedule and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new rabies vaccine given after a possible exposure to rabies (like a bite) to see how well it works and how safe it is. The vaccine is given in a series of shots to help your body fight the rabies virus.
This trial tests whether different batches of a rabies vaccine produce the same immune response. You would receive the vaccine and have blood tests to check your antibody levels, helping ensure the vaccine works consistently.
This trial tests a new rabies-prevention medicine made in a lab. It is for healthy people, not those who have been bitten, and aims to see if the injection is safe and how the body handles it.
This study tests how well a rabies vaccine works and how safe it is for people whose immune systems may be weaker, such as those with certain long-term illnesses, organ transplants, or age 60 and older. It compares them to healthy adults ages 18 to 59.
This study tests a new rabies vaccine given before any exposure to the virus, to help prevent infection. It aims to see if the vaccine is safe and creates a strong immune response in healthy people.
This study tests whether a new experimental rabies vaccine, when given with the standard rabies vaccine, is safe and helps the body build a strong immune response. It aims to find a better way to protect against rabies.
Hear when a new Rabies (Healthy Volunteers) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.